Thus, this clinical trial conducted in immunosuppressed DMD patients showed evidence that allo-transplantation under Tacrolimus immunosuppression of normal myoblasts permitted their fusion with patient myofibers leading to dystrophin expression. This evidence concerns the gene DMD and Duchenne muscular dystrophy.